These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2256711)

  • 1. Accumulation of erythrocyte nucleotides and their pattern in lead workers.
    Sakai T; Araki T; Ushio K
    Arch Environ Health; 1990; 45(5):273-7. PubMed ID: 2256711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythrocyte nucleotides in lead workers.
    Ichiba M; Tomokuni K; Mori K
    Int Arch Occup Environ Health; 1992; 63(6):419-21. PubMed ID: 1544691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on erythrocyte pyrimidine 5'-nucleotidase (P5N) test and its evaluation in workers occupationally exposed to lead.
    Ichiba M; Tomokuni K
    Int Arch Occup Environ Health; 1990; 62(4):305-10. PubMed ID: 2379961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythrocyte nucleotides in children--increased blood lead and cytidine triphosphate.
    Angle CR; McIntire MS; Swanson MS; Stohs SJ
    Pediatr Res; 1982 Apr; 16(4 Pt 1):331-4. PubMed ID: 7079004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal erythrocyte pyrimidine nucleotides in uremic subjects.
    Angle CR; Swanson MS; Stohs SJ; Markin RS
    Nephron; 1985; 39(3):169-74. PubMed ID: 2983249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of lead exposure in workers at a lead-acid battery factory in Korea: with focus on activity of erythrocyte pyrimidine 5'-nucleotidase (P5N).
    Kim Y; Harada K; Ohmori S; Lee BK; Miura H; Ueda A
    Occup Environ Med; 1995 Jul; 52(7):484-8. PubMed ID: 7670624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyrimidine nucleotides impair phosphoribosylpyrophosphate (PRPP) synthetase subunit aggregation by sequestering magnesium. A mechanism for the decreased PRPP synthetase activity in hereditary erythrocyte pyrimidine 5'-nucleotidase deficiency.
    Lachant NA; Zerez CR; Tanaka KR
    Biochim Biophys Acta; 1989 Jan; 994(1):81-8. PubMed ID: 2535789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Reviews on biochemical markers of lead exposure with special emphasis on heme and nucleotide metabolisms].
    Sakai T
    Sangyo Eiseigaku Zasshi; 1995 Mar; 37(2):99-112. PubMed ID: 7749999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of erythrocyte nucleotides in pyrimidine 5'-nucleotidase deficiency.
    Torrance JD; Whittaker D
    Br J Haematol; 1979 Nov; 43(3):423-34. PubMed ID: 497119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythrocyte nucleotides from control and lead-treated rabbits.
    Swanson MS; Angle CR; Stohs SJ; Rovang KS
    Res Commun Chem Pathol Pharmacol; 1980 Feb; 27(2):353-61. PubMed ID: 6245437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A simplified method for determining erythrocyte pyrimidine 5'-nucleotidase (P5N) activity by HPLC and its value in monitoring lead exposure.
    Sakai T; Ushio K
    Br J Ind Med; 1986 Dec; 43(12):839-44. PubMed ID: 3026435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pyrimidine nucleotides accumulated in erythrocytes of lead workers].
    Sakai T; Takeuchi Y; Ikeya Y; Araki T; Ushio K
    Sangyo Igaku; 1989 Sep; 31(5):372-3. PubMed ID: 2555612
    [No Abstract]   [Full Text] [Related]  

  • 13. The metabolism of purine and pyrimidine nucleotides in rat cortex during insulin-induced hypoglycemia and recovery.
    Chapman AG; Westerberg E; Siesjö BK
    J Neurochem; 1981 Jan; 36(1):179-89. PubMed ID: 7463044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of activity of erythrocyte pyrimidine 5'-nucleotidase (P5N) in lead exposed workers: with focus on the effect on hemoglobin.
    Kim Y; Yoo CI; Lee CR; Lee JH; Lee H; Kim SR; Chang SH; Lee WJ; Hwang CH; Lee YH
    Ind Health; 2002 Jan; 40(1):23-7. PubMed ID: 11926511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of lead chelation therapy with EDTA in children on erythrocyte pyrimidine 5'-nucleotidase and with cytidine triphosphate levels.
    Swanson MS; Angle CR; Stohs SJ
    Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):497-500. PubMed ID: 6293983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythrocyte pyrimidine 5'-nucleotidase inhibition by acute lead exposure in neonatal rats.
    Konantakieti C; Beuthin FC; Louis-Ferdinand RT
    J Biochem Toxicol; 1986 Sep; 1(3):51-9. PubMed ID: 2856073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between inhibition of erythrocyte pyrimidine 5'-nucleotidase activity and biological response for porphyrin metabolism in workers occupationally exposed to lead.
    Tomokuni K; Ichiba M; Hirai Y; Hasegawa T; Sugimoto K
    Int Arch Occup Environ Health; 1988; 60(6):431-6. PubMed ID: 2842263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythrocyte nucleotide pattern in two children in a Norwegian family with pyrimidine 5'-nucleotidase deficiency.
    Ericson A; de Verdier CH; Hansen TW; Seip M
    Clin Chim Acta; 1983 Oct; 134(1-2):25-33. PubMed ID: 6317231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of blood lead by HPLC assay of erythrocyte pyrimidine 5'-nucleotidase.
    Cook LR; Angle CR; Kubitschek CE; Stohs SJ
    J Anal Toxicol; 1987; 11(1):39-42. PubMed ID: 3029506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lead poisoning: association with hemolytic anemia, basophilic stippling, erythrocyte pyrimidine 5'-nucleotidase deficiency, and intraerythrocytic accumulation of pyrimidines.
    Valentine WN; Paglia DE; Fink K; Madokoro G
    J Clin Invest; 1976 Oct; 58(4):926-32. PubMed ID: 965496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.